Chambal Fertilisers & Chemicals Ltd
Chambal Fertilisers & Chemicals Ltd is engaged in production of Urea from its own manufacturing plants. It also markets/ deals in other fertilisers and agri-inputs. It also has a Joint Venture for manufacture of Phospohric Acid in Morocco.
The company was also engaged in Software business, However, in FY21, it sold assets and transferred certain liabilities of the business to cease the operations of the software business.[1]
- Market Cap ₹ 17,004 Cr.
- Current Price ₹ 424
- High / Low ₹ 439 / 250
- Stock P/E 12.7
- Book Value ₹ 183
- Dividend Yield 1.77 %
- ROCE 16.8 %
- ROE 15.9 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 25.5%
- Debtor days have improved from 35.2 to 23.1 days.
- Company's working capital requirements have reduced from 50.6 days to 27.7 days
Cons
- Promoters have pledged 25.2% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Fertilizers Industry: Fertilizers
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6,461 | 7,337 | 7,977 | 8,877 | 8,770 | 7,411 | 7,461 | 10,095 | 12,206 | 12,719 | 16,069 | 27,773 | 18,922 | |
5,664 | 6,661 | 7,360 | 8,171 | 8,127 | 6,670 | 6,666 | 8,880 | 10,280 | 10,246 | 13,804 | 25,949 | 16,933 | |
Operating Profit | 797 | 676 | 617 | 706 | 643 | 740 | 795 | 1,214 | 1,926 | 2,473 | 2,265 | 1,824 | 1,989 |
OPM % | 12% | 9% | 8% | 8% | 7% | 10% | 11% | 12% | 16% | 19% | 14% | 7% | 11% |
146 | 135 | 160 | 26 | -154 | 176 | 143 | -56 | 190 | 65 | 96 | 256 | 363 | |
Interest | 121 | 132 | 200 | 158 | 261 | 247 | 151 | 247 | 504 | 290 | 109 | 320 | 204 |
Depreciation | 262 | 222 | 230 | 173 | 87 | 62 | 63 | 119 | 287 | 289 | 300 | 308 | 311 |
Profit before tax | 560 | 457 | 346 | 400 | 142 | 607 | 724 | 793 | 1,326 | 1,959 | 1,952 | 1,452 | 1,838 |
Tax % | 56% | 33% | 12% | 41% | 108% | 30% | 34% | 31% | 8% | 31% | 34% | 26% | |
247 | 306 | 303 | 237 | -11 | 425 | 480 | 545 | 1,224 | 1,347 | 1,287 | 1,069 | 1,343 | |
EPS in Rs | 5.94 | 7.34 | 7.28 | 5.69 | -0.27 | 10.21 | 11.54 | 13.10 | 29.42 | 32.36 | 30.92 | 25.69 | 32.28 |
Dividend Payout % | 32% | 26% | 26% | 33% | -710% | 19% | 16% | 15% | 14% | 23% | 24% | 29% |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 30% |
3 Years: | 32% |
TTM: | -31% |
Compounded Profit Growth | |
---|---|
10 Years: | 14% |
5 Years: | 17% |
3 Years: | -5% |
TTM: | 15% |
Stock Price CAGR | |
---|---|
10 Years: | 26% |
5 Years: | 22% |
3 Years: | 25% |
1 Year: | 44% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 24% |
3 Years: | 22% |
Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 416 | 416 | 414 | 414 | 416 | 416 | 416 | 416 | 416 | 416 | 416 | 416 | 416 |
Reserves | 1,362 | 1,576 | 1,772 | 1,902 | 1,790 | 2,119 | 2,482 | 2,824 | 3,500 | 4,876 | 5,767 | 6,460 | 7,217 |
3,557 | 5,115 | 4,547 | 3,950 | 4,807 | 4,153 | 5,609 | 8,545 | 9,635 | 3,866 | 4,264 | 3,279 | 2,223 | |
985 | 1,334 | 1,043 | 1,008 | 940 | 1,360 | 929 | 2,060 | 1,017 | 1,069 | 2,565 | 2,358 | 3,669 | |
Total Liabilities | 6,320 | 8,441 | 7,776 | 7,274 | 7,952 | 8,047 | 9,436 | 13,846 | 14,567 | 10,227 | 13,012 | 12,514 | 13,526 |
2,636 | 2,599 | 2,632 | 2,551 | 1,716 | 1,099 | 1,169 | 6,846 | 6,701 | 6,480 | 6,358 | 6,262 | 6,176 | |
CWIP | 54 | 44 | 43 | 92 | 626 | 1,707 | 4,129 | 109 | 85 | 161 | 157 | 103 | 95 |
Investments | 492 | 544 | 560 | 487 | 316 | 291 | 291 | 327 | 289 | 303 | 303 | 2,140 | 4,143 |
3,138 | 5,253 | 4,541 | 4,144 | 5,294 | 4,951 | 3,847 | 6,564 | 7,492 | 3,283 | 6,195 | 4,008 | 3,112 | |
Total Assets | 6,320 | 8,441 | 7,776 | 7,274 | 7,952 | 8,047 | 9,436 | 13,846 | 14,567 | 10,227 | 13,012 | 12,514 | 13,526 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-583 | -1,240 | 843 | 986 | -27 | 1,249 | 1,163 | -1,155 | 843 | 6,951 | -33 | 3,241 | |
8 | -112 | 8 | -56 | -311 | -717 | -1,763 | -1,111 | -541 | -255 | -119 | -1,873 | |
613 | 1,243 | -991 | -934 | 348 | -457 | 568 | 2,260 | -218 | -5,943 | -213 | -1,862 | |
Net Cash Flow | 37 | -109 | -141 | -3 | 10 | 75 | -33 | -5 | 84 | 753 | -364 | -494 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 114 | 171 | 157 | 125 | 160 | 149 | 123 | 174 | 166 | 34 | 49 | 23 |
Inventory Days | 49 | 102 | 50 | 48 | 54 | 65 | 63 | 79 | 60 | 39 | 119 | 25 |
Days Payable | 25 | 39 | 15 | 14 | 28 | 17 | 23 | 59 | 29 | 19 | 57 | 22 |
Cash Conversion Cycle | 138 | 235 | 193 | 160 | 186 | 197 | 163 | 195 | 198 | 54 | 111 | 26 |
Working Capital Days | 116 | 185 | 161 | 130 | 169 | 175 | 145 | 151 | 163 | 43 | 81 | 28 |
ROCE % | 15% | 9% | 8% | 10% | 11% | 12% | 11% | 12% | 14% | 20% | 21% | 17% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 9h
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11h - An Analysts / Investors conference call on the financial results of the Company for the quarter and year ended March 31, 2024, will be held …
-
Announcement Under Regulation 30
1d - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
- Board Meeting Intimation for Approving, Inter-Alia, The Standalone And Consolidated Audited Financial Results Of The Company And Recommend Final Dividend, If Any, For The Financial Year Ended March 31, 2024. 27 Apr
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 26 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Jan 2022TranscriptNotesPPT
-
Jan 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Sep 2020TranscriptNotesPPT
-
Jul 2020Transcript PPT
-
May 2020Transcript PPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
May 2019Transcript PPT
-
Feb 2019TranscriptNotesPPT
-
Oct 2018TranscriptNotesPPT
-
Jul 2018TranscriptNotesPPT
-
May 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Oct 2017Transcript PPT
-
Aug 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
May 2016TranscriptNotesPPT
Business Overview
Company is engaged in manufacturing Urea. It is also engaged in marketing of other fertilisers such as Di-Ammonium Phosphate (“DAP”), Muriate of Potash (“MOP”), NPK fertilisers, Speciality Plant Nutrients and Crop Protection Chemicals. Through JV it is engaged in the manufacture of phosphoric acid in Morocco. [1]